ACSM4 polymorphisms are associated with rapid AIDS progression in HIV-infected patients

J Acquir Immune Defic Syndr. 2014 Jan 1;65(1):27-32. doi: 10.1097/QAI.0b013e3182a990e2.

Abstract

: Our aim was to explore the association among ACSM4 and PECI polymorphisms and AIDS progression in 454 HIV-infected patients never treated with antiretroviral drugs (146 long-term nonprogressors, 228 moderate progressors, and 80 rapid progressors). For ACSM4 polymorphisms, rs7137120 AA/AG and rs7961991 CC/CT genotypes had higher odds of having a rapid AIDS progression [odds ratio (OR) = 3.21; 95% of confidence interval (95% CI) = 1.26 to 8.16; P = 0.014 and OR = 3.60; 95% CI = 1.38 to 9.36; P = 0.009, respectively]. Additionally, the ACSM4 haplotype integrated for both rs7961991 A and rs7137120 C alleles had higher odds of having a rapid AIDS progression (OR = 2.85; 95% CI = 1.28 to 6.25; P = 0.010). For PECI polymorphisms, no significant associations were found. In conclusion, ACSM4 polymorphisms might play a significant role in AIDS progression.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • CD4 Lymphocyte Count
  • Case-Control Studies
  • Coenzyme A Ligases / genetics*
  • Coenzyme A Ligases / physiology
  • Cross-Sectional Studies
  • Disease Progression
  • Female
  • HIV Infections / genetics*
  • HIV Infections / physiopathology
  • HIV Long-Term Survivors
  • Humans
  • Male
  • Middle Aged
  • Polymorphism, Single Nucleotide / genetics*
  • Young Adult

Substances

  • Coenzyme A Ligases
  • ACSM4 protein, human